Halyard 24-Hour Oral Care Kit q2, contains 2x15 mL Unit Dose Cups 0.12% Chlorhexidine Gluconate O...
FDA Drug Recall #D-1089-2017 — Class III — July 12, 2017
Recall Summary
| Recall Number | D-1089-2017 |
| Classification | Class III — Low risk |
| Date Initiated | July 12, 2017 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Akorn Inc |
| Location | Lake Forest, IL |
| Product Type | Drugs |
| Quantity | 40,978 unit dose cups |
Product Description
Halyard 24-Hour Oral Care Kit q2, contains 2x15 mL Unit Dose Cups 0.12% Chlorhexidine Gluconate Oral Rinse. Manufactured by Halyard Health Inc., 5405 Windward Parkway, Alpharetta, GA 30004. Distributed by Halyard Sales, LLC Alpharetta, GA 30004. REF # 97012
Reason for Recall
Crystallization with subpotent out of specification assay results for chlorhexidine.
Distribution Pattern
Nationwide in the USA
Lot / Code Information
Lots: 0202623109, 0202623110, 0202623111, 0202630207, 0202630208, 0202630209, EXP 06-2018; 0202642227, 0202642228, 0202647413, 0202647414, 0202653433, 0202653434, EXP 07-2018.
Other Recalls from Akorn Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-1258-2020 | Class III | Fentanyl Citrate Injection, USP, 100 mcg/2 mL (... | Mar 25, 2020 |
| D-0839-2020 | Class II | Hydrocortisone and Acetic Acid Otic Solution, U... | Dec 16, 2019 |
| D-1392-2019 | Class III | Myorisan (isotretinoin capsules, USP), 40 mg, p... | Jun 7, 2019 |
| D-1241-2019 | Class III | Fentanyl Citrate Injection, USP, 100 mcg/2 mL (... | Apr 23, 2019 |
| D-1011-2019 | Class II | Hydrocortisone and Acetic Acid Otic Solution, U... | Mar 12, 2019 |
Frequently Asked Questions
Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.